Archive: News
-
Durvalumab Plus Chemotherapy Maintains OS Benefit in Advanced Biliary Tract Cancer
Dr. Aiwu Ruth He discusses her biliary tract cancer research presented at ESMO GI
Category: News
-
GI Oncology at ASCO 2022: Tumor Sidedness, ctDNA, and MRD
Dr. John L. Marshall and Dr. Mark A. Lewis discuss the most interesting GI research from ASCO 2022
Category: News
-
Use of Circulating Tumor DNA to Assess Minimal Residual Disease in Gastrointestinal Cancers
Circulating tumor DNA (ctDNA) is a promising, non-invasive biomarker with the potential to identify the earliest signs of cancer relapse.
Category: News
-
Trends and Disparities in Treatment Approaches for Patients With Locoregional ESCC
Dr. Marshall shared insights on contemporary approaches to treating localized ESCC and existing racial disparities in treatment.
Category: News
-
A Survey of Patient Presentation, Testing, and Diagnosis in ESCC
Broad discussion from John Marshall, MD, on the current standards of diagnosis care in esophageal squamous cell carcinoma (ESCC).
Category: News
-
The Ruesch Report
Welcome to The Ruesch Report, the e-newsletter from the Ruesch Center for the Cure of Gastrointestinal Cancers. We hope you'll take a few minutes to read our past Ruesch Report Issue e-newsletters. W
Category: News
-
ASCO GI22: Pivotal Studies in Pancreatic Cancer with Dr. Marcus Noel
Dr. Marcus Noel summarizes the latest pancreatic cancer developments and data from the ASCO Gastrointestinal Cancers Symposium 2022.
Category: News
-
ASCO GI22: Pivital Studies in Pancreatic Cancer with Dr. Benjamin Weinberg
Dr. Benjamin Weinberg discusses the data from the TRYbeCA-1, KRYSTAL-1 and CISPD3 trials, which were presented at the ASCO Gastrointestinal Cancers Symposium 2022.
Category: News
-
John Marshall, MD- ASCO GI22: Immune Checkpoint Inhibitors and Neoadjuvant Treatment Options for Esophageal Cancer
Dr. John marshall summarizes the latest developments and data from the ASCO GI Cancers Symposium 2022
Category: News
-
ASCO GI22: Recent Advances in Upper Gastrointestinal Cancers
Dr. John L. Marshall summarises the latest developments and data from the ASCO Gastrointestinal Cancers Symposium 2022
Category: News